This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Lozano, J. Articles by Kolesnick, R. Search for Related Content PubMed PubMed Citation Articles by Lozano, J. Articles by Kolesnick, R.

Deficiency of Kinase Suppressor of Ras1 Prevents Oncogenic Ras Signaling in Mice¹

Laboratory of Signal Transduction [J. L., R. X., Z. C., R. K.] and Molecular Biology Program [W. M.], Sloan-Kettering Institute, Memorial Sloan-Kettering Cancer Center, New York, New York 10021, and Laboratory of Environmental Carcinogenesis and Mutagenesis, National Institute of Environmental Health Sciences, Research Triangle Park, North Carolina 27709 [H. L. J., C. T., R. C.]

In Drosophila and Caenorhabditis elegans, kinase suppressor of ras (KSR) positively modulates Ras/Raf-mitogen-activated protein kinase (MAPK) signaling. The precise signaling mechanism of mammalian KSR1 and its role in Ras-mediated transformation, however, remain uncertain. To gain insight into KSR1 function in vivo, we generated mice homozygous null for KSR1. ksr1-/- mice are viable and without major developmental defects. However, an unusual disorganized hair follicle phenotype manifest in epidermal growth factor receptor knockout mice is recapitulated in ksr1-/- mice, providing genetic support for the notion that epidermal growth factor receptor, Ras, and KSR1 are on the same signaling pathway in mammals. Furthermore, ksr1-/- mice allow for the definition of KSR1-dependent and -independent mechanisms of c-Raf-1 activation. In embryonic fibroblasts, epidermal growth factor and 12-O-tetradecanoylphorbol-13-acetate activated the MAPK cascade to a similar extent, yet only c-Raf-1 activation by epidermal growth factor depended on KSR1. Moreover, whereas the genesis of polyomavirus middle T antigen (MT)-driven mammary cancer appears independent of KSR1, KSR1 is obligate for v-Ha-ras-mediated skin tumor formation. The growth of MT-driven mammary tumor was moderately slowed in ksr1-/- mice, however, consistent with a decreased rate of proliferation of ksr1-/- cells (T cells and embryonic fibroblasts). Nonetheless, all ksr1-/- animals succumbed to mammary cancer. In contrast, papilloma formation in Tg.AC mice, resulting from skin-specific v-Ha-ras expression, was completely abrogated in the ksr1-/- background. Hence, MT-driven mammary tumor genesis, which is signaled through src and phosphatidylinositol 3'-kinase, appears KSR1 independent, whereas v-Ha-ras-mediated skin cancer, signaled through the Raf-1/MAPK cascade, requires KSR1. These results suggest KSR1 may represent a therapeutic target for Ras/MAPK signaling of human tumorigenesis.

This article has been cited by other articles:

				L. R. Jagemann, L. G. Perez-Rivas, E. J. Ruiz, J. A. Ranea, F. Sanchez-Jimenez, A. R. Nebreda, E. Alba, and J. Lozano The Functional Interaction of 14-3-3 Proteins with the ERK1/2 Scaffold KSR1 Occurs in an Isoform-specific Manner J. Biol. Chem., June 20, 2008; 283(25): 17450 - 17462. [Abstract] [Full Text] [PDF]

				C. W. Rinker-Schaeffer, J. P. O'Keefe, D. R. Welch, and D. Theodorescu Metastasis Suppressor Proteins: Discovery, Molecular Mechanisms, and Clinical Application. Clin. Cancer Res., July 1, 2006; 12(13): 3882 - 3889. [Full Text] [PDF]

				R. L. Kortum, H. J. Johnson, D. L. Costanzo, D. J. Volle, G. L. Razidlo, A. M. Fusello, A. S. Shaw, and R. E. Lewis The Molecular Scaffold Kinase Suppressor of Ras 1 Is a Modifier of RasV12-Induced and Replicative Senescence. Mol. Cell. Biol., March 1, 2006; 26(6): 2202 - 2214. [Abstract] [Full Text] [PDF]

				R. L. Kortum, D. L. Costanzo, J. Haferbier, S. J. Schreiner, G. L. Razidlo, M.-H. Wu, D. J. Volle, T. Mori, H. Sakaue, N. V. Chaika, et al. The Molecular Scaffold Kinase Suppressor of Ras 1 (KSR1) Regulates Adipogenesis Mol. Cell. Biol., September 1, 2005; 25(17): 7592 - 7604. [Abstract] [Full Text] [PDF]

				S. Goodison, J. Yuan, D. Sloan, R. Kim, C. Li, N. C. Popescu, and V. Urquidi The RhoGAP Protein DLC-1 Functions as a Metastasis Suppressor in Breast Cancer Cells Cancer Res., July 15, 2005; 65(14): 6042 - 6053. [Abstract] [Full Text] [PDF]

				M. Kim, Y. Yan, R. L. Kortum, S. M. Stoeger, M. K. Sgagias, K. Lee, R. E. Lewis, and K. H. Cowan Expression of Kinase Suppressor of Ras1 Enhances Cisplatin-Induced Extracellular Signal-Regulated Kinase Activation and Cisplatin Sensitivity Cancer Res., May 15, 2005; 65(10): 3986 - 3992. [Abstract] [Full Text] [PDF]

				M. Salerno, D. Palmieri, A. Bouadis, D. Halverson, and P. S. Steeg Nm23-H1 Metastasis Suppressor Expression Level Influences the Binding Properties, Stability, and Function of the Kinase Suppressor of Ras1 (KSR1) Erk Scaffold in Breast Carcinoma Cells Mol. Cell. Biol., February 15, 2005; 25(4): 1379 - 1388. [Abstract] [Full Text] [PDF]

				G. L. Razidlo, R. L. Kortum, J. L. Haferbier, and R. E. Lewis Phosphorylation Regulates KSR1 Stability, ERK Activation, and Cell Proliferation J. Biol. Chem., November 12, 2004; 279(46): 47808 - 47814. [Abstract] [Full Text] [PDF]

				R. L. Kortum and R. E. Lewis The Molecular Scaffold KSR1 Regulates the Proliferative and Oncogenic Potential of Cells Mol. Cell. Biol., May 15, 2004; 24(10): 4407 - 4416. [Abstract] [Full Text] [PDF]

				T. Vomastek, H.-J. Schaeffer, A. Tarcsafalvi, M. E. Smolkin, E. A. Bissonette, and M. J. Weber Modular construction of a signaling scaffold: MORG1 interacts with components of the ERK cascade and links ERK signaling to specific agonists PNAS, May 4, 2004; 101(18): 6981 - 6986. [Abstract] [Full Text] [PDF]